Literature DB >> 26843385

Overexpression of thyroid hormone receptor β1 altered thyroid hormone-mediated regulation of herpes simplex virus-1 replication in differentiated cells.

Feng Chen1, Robert W Figliozzi1,2, Gautam Bedadala1,3, Jayavardhana Palem3, S Victor Hsia4,5.   

Abstract

Thyroid hormone (T3) has been suggested to play a role in herpes simplex virus 1 (HSV-1) replication. It was previously reported that HSV-1 replication was suppressed by T3 in mouse neuroblastoma cells overexpressing thyroid hormone receptor β1 (TRβ1). Using a human neuro-endocrine cells LNCaP differentiated by androgen deprivation, HSV-1 replication was active but decreased by T3 at very low moi, probably due to low copy of TRβ1. In this study, a recombinant HSV-1 was constructed expressing TRβ1 (HSV-1/TRβ1). Infection of Vero cells (very little TRβ1 expression) with HSV-1/TRβ1 exhibited increased replication in the presence of T3 compared to the counterpart without TRβ1 overexpression. Interestingly, HSV-1/TRβ1 infection of differentiated LNCaP cells showed strong suppression of viral replication by T3 and the removal of hormone did not fully reversed the suppression as was observed in parent virus. Quantitative analyses indicated that ICP0 expression was blocked using HSV-1/TRβ1 for infection during T3 washout, suggesting that overexpression of TRβ1 is likely to delay its inhibitory effect on viral gene expression. Together these results emphasized the importance of TRβ1 in the regulation of HSV-1 replication in differentiated environment with neuronal phenotype.

Entities:  

Keywords:  Differentiation; Herpes simplex virus; Neurons; Plaque assay; Thyroid hormone; Thyroid hormone receptor beta 1

Mesh:

Substances:

Year:  2016        PMID: 26843385      PMCID: PMC4972698          DOI: 10.1007/s13365-016-0423-x

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  47 in total

Review 1.  Physiological and molecular basis of thyroid hormone action.

Authors:  P M Yen
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

2.  Stability and circularization of herpes simplex virus type 1 genomes in quiescently infected PC12 cultures.

Authors:  Ying-Hsiu Su; Michael J Moxley; Alan K Ng; Judy Lin; Robert Jordan; Nigel W Fraser; Timothy M Block
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

3.  Expression of the enhanced green fluorescent protein by herpes simplex virus type 1 (HSV-1) as an in vitro or in vivo marker for virus entry and replication.

Authors:  T P Foster; G V Rybachuk; K G Kousoulas
Journal:  J Virol Methods       Date:  1998-11       Impact factor: 2.014

4.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Purification of the glucocorticoid receptor from rat liver cytosol.

Authors:  O Wrange; J Carlstedt-Duke; J A Gustafsson
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

6.  Effect of a beta-adrenergic antagonist, propranolol, on induced HSV-1 ocular recurrence in latently infected rabbits.

Authors:  H H Garza; J M Hill
Journal:  Curr Eye Res       Date:  1997-05       Impact factor: 2.424

7.  Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression.

Authors:  Nicole J Kubat; Robert K Tran; Peterjon McAnany; David C Bloom
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Ocular reactivation phenotype of HSV-1 strain F(MP)E, a corticosteroid-sensitive strain.

Authors:  Mary Marquart; Partha Bhattacharjee; Xiaodong Zheng; Herbert Kaufman; Hilary Thompson; Emily Varnell; James Hill
Journal:  Curr Eye Res       Date:  2003 Mar-Apr       Impact factor: 2.424

9.  In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice.

Authors:  A Mehta; J Maggioncalda; O Bagasra; S Thikkavarapu; P Saikumari; T Valyi-Nagy; N W Fraser; T M Block
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

10.  Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses.

Authors:  Sarah Watson; Sarah Mercier; Chris Bye; John Wilkinson; Anthony L Cunningham; Andrew N Harman
Journal:  Virol J       Date:  2007-12-03       Impact factor: 4.099

View more
  5 in total

1.  Modulation of Voltage-Gated Sodium Channel Activity in Human Dorsal Root Ganglion Neurons by Herpesvirus Quiescent Infection.

Authors:  Qiaojuan Zhang; Miguel Martin-Caraballo; S Victor Hsia
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

2.  Receipt of thyroid hormone deficiency treatment and risk of herpes zoster.

Authors:  Shao-Chung V Hsia; Lie Hong Chen; Hung-Fu Tseng
Journal:  Int J Infect Dis       Date:  2017-04-24       Impact factor: 3.623

3.  Volatile Organic Compound Gamma-Butyrolactone Released upon Herpes Simplex Virus Type -1 Acute Infection Modulated Membrane Potential and Repressed Viral Infection in Human Neuron-Like Cells.

Authors:  Kevin Rochford; Feng Chen; Yan Waguespack; Robert W Figliozzi; Madan K Kharel; Qiaojuan Zhang; Miguel Martin-Caraballo; S Victor Hsia
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

Review 4.  New insights on thyroid hormone mediated regulation of herpesvirus infections.

Authors:  Robert W Figliozzi; Feng Chen; S Victor Hsia
Journal:  Cell Biosci       Date:  2017-03-21       Impact factor: 7.133

Review 5.  Disturbed Yin-Yang balance: stress increases the susceptibility to primary and recurrent infections of herpes simplex virus type 1.

Authors:  Chang Yan; Zhuo Luo; Wen Li; Xue Li; Robert Dallmann; Hiroshi Kurihara; Yi-Fang Li; Rong-Rong He
Journal:  Acta Pharm Sin B       Date:  2019-06-22       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.